Indexed in SCIE, Scopus, PubMed & PMC
pISSN 1226-4512 eISSN 2093-3827


home Article View

Original Article

Korean J Physiol Pharmacol 2023; 27(5): 427-436

Published online September 1, 2023

Copyright © Korean J Physiol Pharmacol.

Mad2B forms a complex with Cdc20, Cdc27, Rev3 and Rev1 in response to cisplatin-induced DNA damage

Ju Hwan Kim1,* and Rajnikant Patel2

1Department of Pharmacology, College of Medicine, Dankook University, Cheonan 31116, Korea, 2Department of Molecular and Cell Biology, University of Leicester, Leicester LE1 7RH, UK

Correspondence to:Ju Hwan Kim

Author contributions: J.H.K. and R.P. conceived and designed the experiment. J.H.K. performed all experiments. J.H.K. and R.P. analyzed and/or interpreted the data. R.P. supervised and coordinated the study. J.H.K. and R.P. wrote the manuscript.

Received: November 4, 2022; Revised: April 18, 2023; Accepted: July 18, 2023

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Mitotic arrest deficient 2 like 2 (Mad2L2, also known as Mad2B), the human homologue of the yeast Rev7 protein, is a regulatory subunit of DNA polymerase ζ that shares high sequence homology with Mad2, the mitotic checkpoint protein. Previously, we demonstrated the involvement of Mad2B in the cisplatin-induced DNA damage response. In this study, we extend our findings to show that Mad2B is recruited to sites of DNA damage in human cancer cells in response to cisplatin treatment. We found that in undamaged cells, Mad2B exists in a complex with Polζ-Rev1 and the APC/C subunit Cdc27. Following cisplatin-induced DNA damage, we observed an increase in the recruitment of Mad2B and Cdc20 (the activators of the APC/C), to the complex. The involvement of Mad2B-Cdc20-APC/C during DNA damage has not been reported before and suggests that the APC/C is activated following cisplatin-induced DNA damage. Using an in vitro ubiquitination assay, our data confirmed Mad2B-dependent activation of APC/C in cisplatin-treated cells. Mad2B may act as an accelerator for APC/C activation during DNA damage response. Our data strongly suggest a role for Mad2B-APC/C-Cdc20 in the ubiquitination of proteins involved in the DNA damage response.

Keywords: Anaphase-promoting complex-cyclosome, Cell division cycle 20, DNA damage, DNA polymerase ζ, Mad2B